China Health Group Inc. (HKG:8225)

Market Cap	143.33M -27.6%
Revenue (ttm)	32.63M +20.6%
Net Income	-14.43M
EPS	-0.01
Shares Out	995.35M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	40,000
Average Volume	32,500
Open	0.1420
Previous Close	0.1470
Day's Range	0.1420 - 0.1430
52-Week Range	0.1310 - 0.1980
Beta	-0.46
RSI	41.37
Earnings Date	Mar 27, 2026

About China Health Group

China Health Group Inc., an investment holding company, researches and develops drugs, bio drugs, natural drugs, and synthetic drugs in the People’s Republic of China. The company offers contracted pharmaceutical development and clinical research, and post market; and post launch market research, medical science, and medical market services. It also provides hospital management, clinical research and promotion, rehabilitation tourism, and specialty hospital services, as well as Wanquan cloud health services. In addition, the company offers phar...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1998
• Employees: 44
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 8225

Financial Performance

In 2024, China Health Group's revenue was 26.45 million, an increase of 23.47% compared to the previous year's 21.43 million. Losses were -14.52 million, -74.97% less than in 2023.

Financial numbers in CNY